Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2009

View Archived Issues

Novel proteasome inhibitors claimed by Millennium Pharmaceuticals

FX-06 limits infarct size in myocardial infarction

CSA-13 exhibits potent bactericidal activity against cariogenic and periodontopathic bacteria

FDA approves Insmed's Iplex for ALS under IND applications

PolyMedix reports results from first-in-man phase I clinical study of PMX-60056

Roche and Genentech agree to merge

FDA approves expanded indication for peginterferon-based combination therapy

Gilead Sciences to acquire CV Therapeutics

AGI announces results from phase II AGI-004 proof-of-concept study

Sutent increases progression-free survival in advanced pancreatic islet cell tumors

Phase III Rituxan study did not meet primary endpoint in lupus nephritis

Dimebolin safe, improves cognition in Huntington's disease patients

Preliminary findings suggest AD-01, AD-02 vaccines are safe in Alzheimer's disease patients

FDA approves Molecular Insight's SPA for phase II registration trial of Azedra

Topical INCB-018424 displays safety and efficacy in patients with psoriasis

QLT completes phase Ia safety trial of QLT-091001 in healthy volunteers

InteKrin completes enrollment in phase IIb study of INT-131 in type 2 diabetes

Ono and Xention sign drug discovery agreement targeting ion channels

Novel skin protease inhibitors may provide new treatment for atopic dermatitis

Oncophage cancer vaccine receives positive orphan drug recommendation

Takeda launches Ecard in Japan

Uloric now available for hyperuricemia in patients with gout

Novel activators of glucokinase developed by Metabasis Therapeutics

Neurogen presents novel heteroaryl amide analogues

Novel beta-secretase inhibitors claimed by CoMentis and Purdue Research Foundation

Novartis presents novel GABA-A receptor ligands

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026